<\/p>\n
UCF students and healthcare providers prepare for the impact of Florida\u2019s SB 844, a new law mandating specialized training to improve pain management and care for sickle cell patients.\u00a0This package aired in the May 1 Newscast, anchored by Edgar Rodriguez.<\/p>\n
Claire Macchiarola
\n
<\/p>\n
The sun reflects off the glass of the Student Union as thousands of students navigate the\u00a0winding\u00a0paths of UCF. Among the students walking to class, one of them\u00a0often\u00a0has to\u00a0fight\u00a0an invisible battle within her body.\u00a0<\/p>\n
You would never know her blood cells are sickled, crescent shapes that occasionally become stuck in the narrowest vessels of her heart and limbs. You\u00a0wouldn’t\u00a0know when\u00a0junior visual communication major with a minor in event management,\u00a0Ezinaye\u00a0Ibiam,\u00a0is in a pain crisis, because she still\u00a0has to\u00a0move through life as normal, and her pain is invisible.<\/p>\n
“I’m not a big crier. I don’t really do stuff like that,” Ibiam said. “But sometimes, I have to, like, bring my mask down and really let them feel how much pain I’m in.”<\/p>\n
<\/p>\n
Junior visual communication major, Ezinaye Ibiam,\u00a0experiences the challenges of navigating the healthcare system while living with sickle cell disease. A new Florida mandate,\u00a0SB 844, aims to standardize pain management training for medical professionals, a move Ibiam says is vital for patients whose symptoms are often unseen.<\/p>\n
Claire Macchiarola<\/p>\n
Sickle cell disease<\/a>\u00a0is an inherited blood disorder where atypical hemoglobin molecules distort red blood cells into those rigid\u00a0crescents.\u00a0According to the\u00a0National Institute of Health<\/a>, this reduces oxygen flow and causes complications ranging from anemia to strokes.\u00a0<\/p>\n It is a global struggle, affecting an estimated\u00a07.74 million<\/a>\u00a0people\u00a0worldwide.\u00a0The impact is particularly acute in Florida, which has the\u00a0highest number of sickle cell cases<\/a>\u00a0in the United States, with more than\u00a014,000 individuals\u00a0identified\u00a0in state data.\u00a0<\/p>\n While Florida is the national epicenter of the sickle cell crisis, Central and South Florida are\u00a0verified\u00a0regional “hotspots” for the disease. For\u00a0the thousands\u00a0of residents and students like\u00a0Ibiam\u00a0navigating this landscape,\u00a0the physical\u00a0pain is often compounded by a medical system that has\u00a0historically lacked standardized training<\/a>\u00a0in SCD management.\u00a0<\/p>\n However, a new state law,\u00a0Florida Senate Bill 844<\/a>, aims to bridge this gap by mandating specialized continuing education for healthcare providers, potentially shifting the standard of care on campus and beyond.<\/p>\n The need for legislative intervention is underscored by the state’s unique health profile. A\u00a0Florida Medicaid study<\/a>\u00a0reveals\u00a0that the prevalence rate of SCD in Florida Medicaid is\u00a0twice the national average, with an average of\u00a07,328 enrollees affected annually<\/a>.\u00a0The research highlights that the highest concentration of these patients\u00a0lives\u00a0in\u00a0Central and South Florida, and the population is\u00a0predominantly young,\u00a0with a median age of 18, and Black, coming in at 63%.\u00a0<\/p>\n Because the pain of a “crisis” is invisible, patients\u00a0can\u00a0often face a second battle in the emergency room. According to research cited in\u00a0Florida Senate bill analyses<\/a>, SCD patients frequently report delayed or inadequate care.\u00a0National data<\/a>\u00a0has shown they may wait significantly longer for pain medication than those with other excruciating conditions, like kidney stones.\u00a0<\/p>\n According to the 2023 Florida\u00a0Medicaid Study of Enrollees with Sickle Cell Disease, “geographically, the highest number of Florida Medicaid recipients with SCD lived in Central Florida (AHCA Regions 6 and 7) and South Florida (AHCA Regions 10 and 11).”<\/p>\n Courtesy of Florida Medicaid<\/p>\n Since pain management requires high doses of opioids, patients who know their treatment plans may be labeled as “drug seekers.” Research hosted by the National Institutes of Health quantifies the severity of this crisis, revealing that roughly\u00a048% of patients<\/a>\u00a0report being treated as drug seekers in emergency settings. This stigma causes many to avoid the emergency room, with\u00a067% of adults<\/a>\u00a0with sickle cell disease reporting that they delay seeking emergency care specifically due to disease-related stigma.<\/p>\n This hesitation is often born from systemic bias within the medical field. Research shows that\u00a063% of nurses<\/a>\u00a0incorrectly believe addiction is prevalent among this population, despite opioid misuse rates being no higher than those of other chronic pain groups.<\/p>\n This skepticism even manifests in official records; an NIH-funded study found that clinical notes for sickle cell patients are\u00a0over twice as likely<\/a>\u00a0to contain negative descriptors like “refuse” or “noncompliant” compared to other Black patients, further cementing a barrier between the patient and life-saving care.<\/p>\n<\/p>\n